08.15.14
Eurofins Genomics has received ISO17025:2005 accreditation according to standards demonstrating high quality molecular testing. ISO 17025 is an international analytical standard used by testing and calibration labs covering mass spectrometry based DNA analysis and molecular testing methods. The company has been successfully accredited for the past seven years, and has been expanded to include more analytical applications.
Eurofins provides analytical testing services under the ISO17025 quality standard for applications in pharmaceutical testing, and in healthcare for medical lab testing for clinical studies and genetic diagnostics, as well as veterinary, food, feed and commodity testing. In April 2014, next generation sequencing (NGS) technologies based on Illumina and Roche 454 platforms were added to extend Eurofins’ ISO17025 service portfolio.
"The addition of our next generation sequencing services to our ISO17025 accreditation was the next logical step in response to our growing customer base in the regulated market and in areas with specific quality assurance needs," said Peter Persigehl, general manager Eurofins Genomics Europe.
Eurofins provides analytical testing services under the ISO17025 quality standard for applications in pharmaceutical testing, and in healthcare for medical lab testing for clinical studies and genetic diagnostics, as well as veterinary, food, feed and commodity testing. In April 2014, next generation sequencing (NGS) technologies based on Illumina and Roche 454 platforms were added to extend Eurofins’ ISO17025 service portfolio.
"The addition of our next generation sequencing services to our ISO17025 accreditation was the next logical step in response to our growing customer base in the regulated market and in areas with specific quality assurance needs," said Peter Persigehl, general manager Eurofins Genomics Europe.
